GET THE APP

..

Cancer Science & Therapy

ISSN: 1948-5956

Open Access

Citations Report

Cancer Science & Therapy : Citations & Metrics Report

Articles published in Cancer Science & Therapy have been cited by esteemed scholars and scientists all around the world.

Cancer Science & Therapy has got h-index 27, which means every article in Cancer Science & Therapy has got 27 average citations.

Following are the list of articles that have cited the articles published in Cancer Science & Therapy.

  2024 2023 2022 2021 2020 2019 2018

Total published articles

57 46 70 59 42 78 71

Research, Review articles and Editorials

3 4 18 22 27 26 69

Research communications, Review communications, Editorial communications, Case reports and Commentary

41 45 52 37 15 52 2

Conference proceedings

0 21 45 12 0 162 404

Citations received as per Google Scholar, other indexing platforms and portals

4129 3358 294 348 345 373 344
Journal total citations count 5332
Journal impact factor 2.06
Journal 5 years impact factor 2.85
Journal cite score 6.17
Journal h-index 27
Journal h-index since 2019 18
Important citations

Lorenzo VP, Mendonça Júnior FJ, Scotti L, Scotti MT (2016) Theoretical Study of Phosphoethanolamine: A Synthetic Anticancer Agent with Broad Antitumor Activity. Journal of Chemistry.

Saxena R, Yang C, Rao M, Turaga RC, Garlapati C, at al. (2017) Preclinical development of a non-toxic oral formulation of monoethanolamine, a lipid precursor, for prostate cancer treatment. Clinical Cancer Research, clincanres-1716.

Naga Anusha P, Siddiqui A, Hima Bindu A (2011) Immuno Defense Mechanism against Tumors. J Cancer Sci Ther S 17: 2.

Arun Kumar R, Sathish Kumar D, Nishanth T (2011) A Review on Stem cell Research & Their Role in Various Diseases. J Stem Cell Res Ther 1(3: 1-5.

Karanova MV (2013) Influence of Low Temperature on the Evolution of Amino Acid Pools Adaptive Modifications inPoikilothermal Animals. International Journal of Biochemistry and Biophysics 1(2): 33-40.

Siddiqui A, Jeevani T, Naga Anusha P, Hima Bindu A (2011) Stem cell therapy for liver diseases. J Stem Cell Res Ther 1(111): 2.

Azevedo RA, Ferreira AK, Auada AV, Pasqualoto KF, et al. (2012) Antitumor effect of cationic INKKI peptide from bovine β-casein on melanoma B16F10.

Ferreira AK, Meneguelo R, Marques FL, Radin A, R Filho OM, et al. (2012) phosphoethanolamine a precursor of membrane phospholipids reduce tumor growth in mice bearing melanoma B16-F10 and in vitro induce apoptosis and arrest in G2/M phase. Biomedicine & Pharmacotherapy 66(7): 541-548.

Ferreira AK, Freitas VM, Levy D, Ruiz JL, Bydlowski SP (2013) Anti-angiogenic and anti-metastatic activity of synthetic phosphoethanolamine. PLoS One 8(3): e57937.

Ferreira AK, Freitas VM, Levy D, Ruiz JL, Bydlowski SP (2013 Anti-angiogenic and anti-metastatic activity of synthetic phosphoethanolamine. PLoS One 8(3): e57937.

Engel N, Lisec J, Piechulla B, Nebe B (2012 Metabolic profiling reveals sphingosine-1-phosphate kinase 2 and lyase as key targets of (phyto-) estrogen action in the breast cancer cell line MCF-7 and not in MCF-12A. PLoS One 7(10: e47833.

Tata A, Fernandes AM, Santos VG, Alberici RM, Araldi D (2012) Nanoassisted laser desorption-ionization-MS imaging of tumors. Analytical chemistry 84(15):6341-6345.

Ferreira AK, Meneguelo R, Pereira A, R FILHO OM, Chierice GO (2012) Anticancer effects of synthetic phosphoethanolamine on Ehrlich ascites tumor: an experimental study. Anticancer research 32(1):95-104.

Pabst TM, Wendeler M, Wang X, Bezemer S, Hermans P, et al. (2017 affinity ligands enable separation of closely related biopharmaceuticals. Biotechnology Journal 12: 2

Naga Anusha P, Siddiqui A, Hima Bindu A (2011) Immuno Defense Mechanism against Tumors. J Cancer Sci Ther S.17: 2.

Linke T, Aspelund MT, Thompson C, Xi G, Fulton A (2014) Development and scale‐up of a commercial fed batch refolding process for an anti‐CD22 two chain immunotoxin. Biotechnology progress 30(6): 1380-1389.

Linke T, Feng J, Yu K, Kim HJ, Wei Z et al. (2012) Process scale separation of an anti-CD22 immunotoxin charge variant. Journal of Chromatography A 1260: 120-125.

Burden RE, Caswell J, Fay F, Scott CJ (2012) Recent advances in the application of antibodies as therapeutics. Future medicinal chemistry 1:73-86.

Madhumathi J, Devilakshmi S, Sridevi S, Verma RS (2016) Immunotoxin therapy for hematologic malignancies: where are we heading?. Drug discovery today 21: 325-332.

Kawa S, Onda M, Ho M, Kreitman RJ, Bera TK, et al. (2011) The improvement of an anti-CD22 immunotoxin: conversion to single-chain and disulfide stabilized form and affinity maturation by alanine scan. InMAbs  3: 479-486.

Google Scholar citation report
Citations: 5332

Cancer Science & Therapy received 5332 citations as per Google Scholar report

Cancer Science & Therapy peer review process verified at publons

Indexed In

 
arrow_upward arrow_upward